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The aim of this study was to investigate the phospholipid fatty acid profile and dietary fatty acids
effects in the liver, lung, spleen and submandibular gland mice tissues. Palmitic (C16:0) and
stearic (C18:0) fatty acids were major saturates in all the tissues studied. Oleic acid (C18:1n-9)
was the major monounsaturated in the phospholipid fraction of all tissues. Docosahexaenoic
acid (C22:6n-3) was the major polyunsaturated in the liver and lung, arachidonic acid (C20:4n-6)
was the major polyunsaturated in the spleen, and linoleic acid (C18:2n-6) in the submandibular
gland tissue samples. Presented data support the hypothesis that corn oil diet induced changes
increase linoleic acid (C18:2n-6), and olive oil increases the oleic acid (C18:1n-9) content in
total phospholipid fatty acid composition in the majority of the examined tissues. Liver tissue
was most affected by the applied diet.
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INTRODUCTION
Lipid and carbohydrate homeostasis in higher organisms
is under the control of integrated systems that have the
capacity to respond rapidly to metabolic changes. Fatty
acids (FAs)1 are energy-rich molecules that play impor-
tant metabolic roles. They are also an integral part of
cells as membrane components, which can influence flu-
idity and receptor or channel functions. Multiple factors
influence the incorporation of dietary FAs into mem-
brane phospholipids (PLs), including growth, type of tis-
sue, differing energy levels in the diet, and weight loss
or gain. Lipid metabolism can be regulated by FAs at
three different levels; they interact with enzymes to af-
fect their activity, they interact with nuclear transcription
factors to modulate gene expression and finally they can
affect mRNA stability and thus regulate the expression
of enzymes.2 The corresponding change in the amount
of specific proteins is an adaptive process that the cells
develop in response to variations in FA concentration in
the vicinity of target tissues.3,4,5,6
Most studies rely on current or retrospective reports
on dietary intake for determining dietary FA intake. In
general, the structures of dietary FAs are important; the
basic structure with specific diversity determined by the
chain length and the degree of unsaturation and FAs
which are rapidly metabolized. Saturated (SFA) and
monounsaturated (MUFA) FAs are obtained either from
the diet or by complete synthesis from acetyl CoA. In
contrast, two major classes of polyunsaturated FAs
(PUFAs), n-3 (or 3) and n-6 (or 6), cannot be synthe-
sized in humans and are essential components of the diet.
This explains why the FA composition of the tissue lipids,
including membrane PLs, can be modified by PUFAs in
the diet. n-3 and n-6 PUFAs may have biologically oppo-
site properties, probably because they give rise to differ-
ent eicosanoid products. For instance, when model ani-
mals with a propensity to develop tumors are fed diets
containing a large proportion of n-6 PUFAs, tumor forma-
tion is favored, whereas diets with a similar proportion of
n-3 PUFAs are somewhat protective.1 Besides genetic
predisposition, diet is also an important risk factor for
various diseases. Diets rich in PUFAs such as linoleic
acid (C18:2n-6) diminish stearoyl-CoA desaturase (SCD)
activity.7 Consequences of regulating the SCD by PUFAs
and cholesterol may be relevant to lipoprotein metabo-
lism.8 Oleic (C18:1n-9) and palmitoleic (C16:1n-7) FAs
are the major MUFAs in fat depots and membrane PLs.
To date, dietary trials have demonstrated the major role of
C18:1n-9 in primary and secondary prevention of lipid
metabolic disorders such as coronary heart disease (CHD).9
The ratio of stearic acid/oleic acid (C18:0/C18:1n-9) is one
of the factors influencing membrane fluidity and cell-cell
interaction.8,10 Abnormal alteration of this ratio has been
shown to play a role in several physiological and disease
states, including diabetes, cardiovascular disease, obe-
sity, hypertension, neurological diseases, immune disor-
ders, cancer, and aging.11–21
The aim of this work was to determine the PLs FA
profile of various tissues and the modulation of these
profiles by dietary fats. For the present study, we used
the n-9 diet (fed virgin olive oil, FOO) and n-6 diet (fed
corn oil, FCO) for determining diet variability and con-
trol of tissue variability. Male Balb/c mice were used to
study the incorporation of FAs into PLs, taken from the
liver, spleen, submandibular gland and lung after a pe-
riod of 3 weeks of dietary intervention.
EXPERIMENTAL
Chemicals and Reagents
All the used chemicals and reference compounds for gas
chromatography (GC) were purchased from Sigma (St. Louis,
MO, USA) and were of the highest reagent grade available.
The compound used for the formulation of diets, the extra-
virgin olive oil sample was obtained from an individual
producer and the refined corn oil sample was obtained from
Oleifico Zucchi S.p.A, Cremona, Italy.
The solid-phase extraction cartridges, NH2 (Bond Elut,
3 ml volume, 500 mg sorbents) used for the lipid classes sepa-
ration were purchased from Varian (Harbor City, CA, USA).
Diets and Animals
The stock standard diet (pellet, type 4RF21 GLP, Mucedola,
Settimo Milanese, Italy) was used as the control diet in all
experiments. The control diet already contained 3 % soy-
bean oil as the fat source. Olive oil (FOO) and corn oil
(FCO) were added to the stock standard diet, in the quantity
of 5 g / 100 g (5 g of oil to 100 g of standard diet pellets).
The total fat content was 3 g in the control, and 8 g in FOO
and FCO diets. Diets were freshly prepared once a week by
the addition of appropriate amounts of oils, gases with N2
and were stored at 0–4 oC to minimize fatty acid degrada-
tion. The FA composition of dietary oils and total fats in the
diets were measured by GC. The composition of FAs in the
used dietary oils and in the diets containing the mentioned
oils (as particular FA fractions expressed in percents) is
given in Table 1.
Male Balb/c mice (Medical Faculty, Rijeka, Croatia),
aged 2–3 months and weighing at least 25 to 30 g, were ac-
climated for 1 week in a temperature (21–23 °C) and humid-
ity controlled facility on a 12-hour light/dark cycle. After
the acclimatization period, the animals were divided into 3
treatment groups of 6 mice each as follows: Group 1 (Con-
trol) control diet; Group 2 (FOO) 5 g/100 g olive oil fed
mice; Group 3 (FCO) 5 g/100 g corn oil fed mice. At the
end of the feeding period, after 3 weeks, the animals were
killed and a portion of each tissue (spleen, lung, submandi-
bular glands and liver) was removed with plastic instru-
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TABLE I. Fatty acid composition of the used diets and dietary oils
expressed in percents(a)
Fatty acid Control
diet
Olive
oil
FOO
diet
Corn
oil
FCO
diet
C14:0 tr. tr. tr. 0.01 tr.
C16:0 18.42 11.36 14.01 13.63 15.43
C18:0 2.83 2.66 2.72 1.44 1.96
C20:0 tr. 0.43 0.27 0.14 0.09
C22:0 tr. tr. tr. 0.05 0.03
C24:0 tr. 0.09 0.06 0.07 0.04
ÓSFA 21.25 14.54 17.06 15.49 17.55
C16:1n-7 0.85 0.93 0.90 0.06 0.36
C18:1n-9 21.19 74.48 54.50 25.37 23.80
C20:1n-9 tr. 0.38 0.24 0.97 0.61
C22:1n-9 tr. tr. tr. 0.76 tr.
ÓMUFA 22.04 75.79 55.63 27.16 24.77
C18:2n-6 51.80 9.00 25.05 57.06 55.09
Ón-6 51.80 9.00 25.05 57.06 55.09
C18:3n-3 4.90 0.67 2.26 0.30 2.03
Ón-3 4.90 0.67 2.26 0.30 2.03
PUFA 56.70 9.67 27.31 57.36 57.11
n-6/n-3 10.57 13.43 11.10 190.20 27.20
C18:0/C18:1n-9 0.13 0.04 0.05 0.06 0.08
(a) FOO, fed olive oil; FCO, fed corn oil; SFA, saturated fatty acid;
MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid.
ments, washed several times with saline solution (0.9 %
NaCl) to remove blood, immediately weighed and stored at
–80 oC until the analysis. Body weight and food intake
were monitored during the study.
Lipid Analyses
The FA composition of the dietary oil was determined ac-
cording to the modified EC Regulation 2568/9122 by GC
analysis within 5 % coefficient of variance. Oils, which
were subjected to analysis, were heated under reflux with
2 M methanol-hydrochloric acid at 100 oC for four hours.
The obtained methyl esters were extracted with petroleum
ether, passed through anhydrous sodium sulphate and evap-
orated in a rotating evaporator to dryness. Total lipids were
extracted from pellets containing 5 g/100 g olive and corn
oil with hexane and then evaporated in a rotating evapora-
tor to dryness. The residue, which was subjected to analy-
sis, was heated under reflux with 2 M methanol-hydrochlo-
ric acid at 100 oC for four hours. The obtained methyl es-
ters were extracted with petroleum ether, passed through
anhydrous sodium sulphate and evaporated in a rotating
evaporator to dryness. Test portions, in the form of fatty
acid methyl esters (FAMEs), were performed in duplicate
and 1 l of each sample solute in hexane was injected.
The PL FA composition in the examined tissues was
determined according to Giacometti et al.23
Total lipids were extracted, according to Folch et al.,24
from tissues with chloroform-methanol (CM, vol. ratio 2:1)
containing 0.01 % butylated hydroxytoluene (BHT) as anti-
oxidant. Lipid extracts were fractionated and purified by so-
lid-phase extraction (SPE) and polar lipids were separated on
the NH2 column.23 FAs of the polar lipids were transme-
thylated with methanol-n-hexane-sulphuric acid (75:25:1) at
90 oC for 90 min, extracted in petrolether and analyzed by
GC. GC analyses of FAMEs were carried out using an Auto-
system XL from Perkin-Elmer with flame-ionization detec-
tion (FID). Chromatography software from Perkin-Elmer
Nelson (Turbochrom 4, rev. 4.1.) was used for data acquisi-
tion from the FID. Hydrogen was obtained with a Claind hy-
drogen generator. An SP-2330 capillary column (Supelco,
Bellefonte, PA, USA), 30 m x 0.32 mm I.D., 0.2 mm film
thickness, was used. Helium was used as the carrier gas with
split injection (100:1). The analyses were carried out in pro-
grammed temperature mode from 140 to 220 oC, at 5 oC
min–1 and then isothermal for 25 min. The detector tempera-
ture was 350 oC and injector temperature was 300 oC. The
results were expressed as percentage of particular fatty acids
in polar lipid fractions.
Statistical Analyses
GC data were evaluated with the Statistica software pack-
age for Windows 2001 by Stat soft, Inc. Statistical analysis
was performed using the nonparametric Kruskal-Wallis
one-way ANOVA by Ranks (variables for which the multi-
ple independent groups were compared) and the Mann-
Whitney U-test (variables for which the two groups were
compared) to assess significant differences between the
groups (tissues) and diets. A linear regression analysis us-
ing the least square method was used for the correlation de-
termination of individual chemical parameters in all tissues.
Statistical significance was assumed at p < 0.05 and data
are reported as mean ± SD.
RESULTS
Animals fed different experimental diets gained compa-
rable amounts of weight during the experimental period,
but there were no statistical differences in weight be-
tween the experimental groups.
The FA composition of the diets and of dietary oils
is shown in Table I. FA analyses of dietary oils showed
that corn oil mainly contained C18:2n-6 (57.06 %) with
an n-6/n-3 FA ratio approximately 190:1, consisting of
total n-6 and n-3 levels of 57.06 and 0.3 %, respectively.
When corn oil was added into the control diet, which
contained 3 % of soybean oil, the diet based on corn oil
(FCO) mainly contained C18:2n-6 (55.09 %) with an
n-6/n-3 ratio approximately 27.2:1, consisting of total
n-6 and n-3 levels of 55.09 and 2.03 %, respectively.
Analysis of the dietary olive oil showed that it mainly
contained C18:1n-9 (74.48 %), and the supplemented ol-
ive oil diet (FOO) with this oil contained 54.5 % oleic
acid. The n-6/n-3 ratio was 13.43:1 in the dietary olive
oil and 11.1:1 in the diet supplemented with olive oil
(FOO). The theoretical content of triacylglycerols with
ECN42 (ECN, equivalent carbon number)22 of the dietary
olive oil (ECN42 = 0.55) and the blends of dietary olive
oil and fat in the control diet (ECN42 = 3.12) showed
different amounts in trilinoleine. Larger differences were
recorded in total n-6 and n-3 of 25.05 and 2.26 % in the FOO
diet than in dietary olive oil (where 9 and 0.67 % were
found). The level of the n-6 fatty acid in the FCO diet
was twice and n-6/n-3 ratio more than twice higher than
in the FOO diet. In contrast, the C18:1n-9 proportion in
the FOO was more than twice higher than in the FCO.
Palmitic (C16:0) and C18:0 FAs were the major sat-
urates in the polar lipids of all studied tissues. C18:1n-9
was the major monounsaturated, docosahexaenoic acid
(C22:6n-3) was the major polyunsaturated in the liver and
lung, arachidonic acid (C20:4n-6) was the major polyun-
saturated in the spleen, and linoleic acid (C18:2n-6) in
the submandibular gland tissue samples in mice fed the
control diet. The C18:1n-9 proportion increased signifi-
cantly in the FOO diet and linoleic acid (C18:2n-6) in
the FCO diet compared to the control in all tissues stud-
ied. The n-9 and n-6 dietary treatments changed FAs
proportions, especially C18:2n-6 and C22:6n-3.
Differences in the FA composition of the total PLs
in the mice liver tissue samples in the control and after
being fed diets supplemented with 5 g/100 g olive oil
(FOO) and 5 g/100 g corn oil (FCO) are shown in Table
II. As shown in Table II, significant differences were ob-
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served in the FA composition of PL fraction in the liver
tissue samples (p = 0.0032). Compared to the control,
significant differences in the liver tissues after feeding
FOO diets were found in the n-3 PUFAs contents such
as C20:5 and C22:6, in the C20:0 content as SFA and in
the C18:1n-9 content as MUFA, also in PUFA/MUFA,
PUFA/SFA, C20:4n-6/C22:6n-3, C18:0/C18:1 and n-6/n-3
ratios. After feeding the FCO diet, significantly different
from the control, in the mice liver PL FAs there were n-6
PUFAs such as C18:2, C20:2 and C20:4; n-3 PUFAs
such as C20:5 and C22:6; SFAs such as C16:0, C18:0
and C20:0 and oleic acid as MUFAs. These differences
were reflected in PUFA/MUFA, C20:4n-6/C22:6n-3 and
C18:0/C18:1 ratios in the liver.
No significant differences in the total PL FAs and
diets studied were found in the lung, spleen and subman-
dibular gland samples in the studied diets. The differen-
ces in the PL FAs in the mice lung tissue samples in the
control and after feeding diets supplemented with 5 g of
olive oil (FOO) and 5 g of corn oil (FCO) to 100 g of
standard diet are shown in Table III. After feeding the
studied diets, more significant differences in the lung tis-
sues were found in the FCO diet (n-6 PUFAs such as
C18:2, C20:2 and C20:3; n-3 PUFAs such as C20:5;
C18:1n-9 as MUFA; also in C18:0/C18:1, n-6/ n-3 and
C16:0/C16:1 ratios) compared to the control. Compara-
ble results relating to the used diet were obtained in C18:
1n-9 and C20:5n-3, where C18:1n-9 was significantly elevat-
ed (p = 0.002) in the FOO diet, and suppressed (p = 0.041) in
the FCO diet. Increases in C16:0/C16:1 and C18:0/
C18:1 ratios occurred in the FCO diet in the lung tissue.
As shown in Tables II, III, IV and V, the levels of
SFAs and C16:0 were the highest in the lung tissues total
PLs in all diets and tissues studied. Although liver and
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TABLE II. Fatty acid composition of the total phospholipids in the
mice liver samples, expressed in percents, in the control group and
after feeding diets supplemented with 5 g of olive oil (FOO) and
5 g of corn oil (FCO) to 100 g of standard diet pellets(a),(b)
Fatty acid Control group FOO group FCO group
C18:2n-6 13.68 ± 1.23 13.86 ± 1.32 17.56 ± 1.10*
C20:2n-6 0.22 ± 0.11 0.18 ± 0.02 0.35 ± 0.02*
C20:3n-6 1.10 ± 0.41 1.53 ± 0.15 1.53 ± 0.15
C20:4n-6 11.02 ± 0.54 10.70 ± 1.17 13.36 ± 0.66*
Ón-6 26.02 ± 1.23 26.27 ± 0.33 32.81 ± 0.77*
C18:3n-3 0.45 ± 0.48 0.37 ± 0.09 0.36 ± 0.03
C20:5n-3 1.09 ± 0.39 0.69 ± 0.08* 0.46 ± 0.06*
C22:6n-3 20.50 ± 1.57 15.15 ± 1.02* 14.74 ± 1.46*
Ón-3 22.04 ± 1.85 16.21 ± 1.06* 15.55 ± 1.46*
ÓPUFA 48.06 ± 1.95 42.48 ± 0.98* 48.36 ± 1.15
C14:0 0.05 ± 0.03 0.06 ± 0.02 0.07 ± 0.02
C16:0 24.90 ± 0.50 25.33 ± 1.93 23.37 ± 0.52*
C18:0 15.98 ± 1.99 16.34 ± 2.53 19.35 ± 0.53*
C20:0 0.31 ± 0.15 0.57 ± 0.13* 0.56 ± 0.08*
C22:0 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
C24:0 0.31 ± 0.27 0.18 ± 0.08 0.13 ± 0.04
ÓSFA 41.55 ± 2.38 42.49 ± 1.09 43.48 ± 0.72
C16:1n-7 0.86 ± 0.21 1.05 ± 0.39 0.68 ± 0.08
C18:1n-9 9.54 ± 1.44 14.06 ± 0.46* 7.48 ± 0.50*
C20:1n-9 0.00 0.00 ± 0.00 0.00 ± 0.00
ÓMUFA 10.40 ± 1.61 15.11 ± 0.75* 8.16 ± 0.55*
ÓUFA 58.45 ± 2.38 57.59 ± 1.04 56.52 ± 0.72
PUFA/MUFA 4.71 ± 0.71 2.82 ± 0.17* 5.95 ± 0.51*
PUFA/SFA 1.16 ± 0.11 1.00 ± 0.05* 1.11 ± 0.04
C20:4n-6/C22:6n-3 0.54 ± 0.05 0.70 ± 0.03* 0.92 ± 0.12*
C18:0/C18:1 1.72 ± 0.41 1.16 ± 0.19* 2.60 ± 0.20*
n-6/n-3 1.19 ± 0.13 1.63 ± 0.12* 2.13 ± 0.23*
C16:0/C16:1 31.43 ± 7.72 26.65 ± 8.43 34.64 ± 4.01
(a) Mean ± SD; calculated on the basis of peak areas; * significantly
different from the control (p<0.05).
(b) Abbreviations: PUFA, polyunsaturated fatty acid; UFA, unsaturated
fatty acid; MUFA, monounsaturated fatty acid; SFA, saturated fatty acid.
TABLE III. Fatty acid composition of the total phospholipids in the
mice lung samples, expressed in percents, in the control group and
after feeding diets supplemented with 5 g of olive oil (FOO) and
5 g of corn oil (FCO) to 100 g of standard diet(a),(b)
Fatty acid Control group FOO group FCO group
C18:2n-6 6.80 ± 0.36 6.99 ± 1.06 8.83 ± 0.59*
C20:2n-6 0.44 ± 0.05 0.38 ± 0.10 0.64 ± 0.10*
C20:3n-6 0.58 ± 0.10 0.77 ± 0.18 0.74 ± 0.07*
C20:4n-6 7.10 ± 0.35 7.61 ± 1.99 6.82 ± 1.22
Ón-6 14.92 ± 0.54 15.75 ± 2.58 17.03 ± 1.71*
C18:3n-3 0.37 ± 0.21 0.54 ± 0.13 0.36 ± 0.10
C20:5n-3 1.49 ± 1.13 0.57 ± 0.02* 0.48 ± 0.05*
C22:6n-3 8.94 ± 0.48 9.96 ± 2.32 8.18 ± 2.35
Ón-3 10.79 ± 1.17 11.07 ± 2.25 9.02 ± 2.35
ÓPUFA 25.71 ± 1.36 26.81 ± 4.66 26.05 ± 3.37
C14:0 1.00 ± 0.09 0.99 ± 0.30 1.18 ± 0.29
C16:0 48.86 ± 1.21 43.51 ± 4.29* 48.97 ± 3.80
C18:0 8.93 ± 0.34 9.99 ± 1.53 9.53 ± 0.49
C20:0 0.23 ± 0.09 0.23 ± 0.12 0.28 ± 0.26
C22:0 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
C24:0 0.33 ± 0.15 0.40 ± 0.11 1.12 ± 0.97
ÓSFA 59.35 ± 1.29 55.13 ± 4.44 61.08 ± 3.66
C16:1n-7 4.09 ± 0.05 3.65 ± 0.84 3.33 ± 0.57
C18:1n-9 10.85 ± 0.67 14.41 ± 1.82* 9.53 ± 0.90*
C20:1n-9 0.00 0.00 ± 0.00 0.00 ± 0.00
ÓMUFA 14.94 ± 0.72 18.06 ± 2.61* 12.86 ± 1.17*
ÓUFA 40.65 ± 1.29 44.87 ± 4.44 38.92 ± 3.66
PUFA/MUFA 1.73 ± 0.15 1.52 ± 0.37 2.04 ± 0.31
PUFA/SFA 0.43 ± 0.03 0.49 ± 0.12 0.43 ± 0.08
C20:4n-6/C22:6n-3 0.80 ± 0.06 0.76 ± 0.06 0.88 ± 0.25
C18:0/C18:1 0.83 ± 0.06 0.71 ± 0.18 1.01 ± 0.11*
n-6/n-3 1.39 ± 0.15 1.44 ± 0.11 1.99 ± 0.50*
C16:0/C16:1 11.95 ± 0.38 12.42 ± 2.94 14.97 ± 2.20*
(a) Mean ± SD, calculated on the basis of peak areas; * significantly
different from the control (p<0.05).
(b) Abbreviations: PUFA, polyunsaturated fatty acid; UFA, unsaturated
fatty acid; MUFA, monounsaturated fatty acid; SFA, saturated fatty acid.
spleen are lymphatic organs, their total PL FAs composi-
tion was different. The FCO diet significantly elevated
n-6 FAs in the liver while the FOO diet significantly sup-
pressed n-6 FAs in the spleen, especially in the C18:2n-6.
A higher content of dietary C18:1n-9 in FOO diets sig-
nificantly decreased PUFAs (n-6 PUFAs) and increased
C18:1n-9 compared to the spleen control. A lower C18:0/
C18:1 ratio compared to the control suggests an increase
in the SCD activity in the spleen in the FOO group.
The FOO diet significantly decreased C20:5n-3 when
C18:0, C18:1n-9, and C16:0/16:1 ratio increased, but did
not change the C18:0/C18:1 ratio in the submandibular
gland. As shown in Table IV, more differences were found
in the FCO diet, where C18:0, C18:2n-6, C20:2n-6 and
C18:3n-3 were significantly increased, and C16:1n-7 and
C20:5n-3 were decreased. The C16:0/C16:1 and C18:0/
C18:1 ratios were significantly increased in the FCO diet.
Comparing all studied tissues (total number of sam-
ples was 24 divided into four groups of 6), significant
correlations were found between C20:4n-6/C22:6n-3 and
n-6/n-3 (r = 0.77 in the control; r = 0.66 in the FOO; r =
0.80 in the FCO), as shown in Figure 1. Significant cor-
relation between C18:0/C18:1n-9 and C16:0/C16:1n-7
ratios in tissues was found only in the control diet.
DISCUSSION
Lipid metabolism is very complex and can be affected
by many parameters such as diet, oxidative stress, drugs,
etc. PLs are major structural components of cells and
intracellular membranes in all living organisms. Dietary
induced changes in membranes are recognized as func-
tionally important for a specific role of membrane lipids
in modulating membrane function. Nutritional balance
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TABLE IV. Fatty acid composition of the total phospholipids in the
mice spleen samples, expressed in percents, in the control group
and after feeding diets supplemented with 5 g of olive oil (FOO)
and 5 g of corn oil (FCO) to 100 g of standard diet(a),(b)
Fatty acids Control group FOO group FCO group
C18:2n-6 8.71 ± 1.22 7.90 ± 0.44 12.10 ± 2.40*
C20:2n-6 0.81 ± 0.09 1.11 ± 0.22* 1.25 ± 0.17*
C20:3n-6 0.86 ± 0.09 0.73 ± 0.28 0.56 ± 0.04*
C20:4n-6 13.97 ± 1.19 11.92 ± 1.53 13.91 ± 1.08
Ón-6 24.35 ± 1.79 21.65 ± 1.43* 27.82 ± 3.19
C18:3n-3 0.73 ± 0.10 1.00 ± 0.25* 0.61 ± 0.12
C20:5n-3 0.83 ± 0.13 0.84 ± 0.19 0.68 ± 0.14
C22:6n-3 10.46 ± 1.75 8.81 ± 1.20 9.92 ± 1.47
Ón-3 12.02 ± 1.74 10.66 ± 1.22 11.21 ± 1.37
ÓPUFA 36.37 ± 2.56 32.31 ± 2.08* 39.02 ± 3.64
C14:0 0.49 ± 0.08 0.51 ± 0.14 0.47 ± 0.08
C16:0 33.86 ± 2.26 34.42 ± 3.95 32.36 ± 3.41
C18:0 13.98 ± 1.65 13.31 ± 2.51 13.35 ± 0.81
C20:0 0.54 ± 0.26 0.33 ± 0.27 0.30 ± 0.08
C22:0 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
C24:0 1.12 ± 0.47 0.78 ± 0.66 0.47 ± 0.18*
ÓSFA 49.99 ± 2.76 49.35 ± 4.14 46.95 ± 3.84
C16:1n-7 1.63 ± 0.46 1.66 ± 0.59 1.20 ± 0.30
C18:1n-9 12.00 ± 0.49 16.68 ± 2.17* 12.73 ± 0.97
C20:1n-9 0.00 0.00 ± 0.00 0.10 ± 0.14
ÓMUFA 13.64 ± 0.76 18.34 ± 2.43* 14.03 ± 0.97
ÓUFA 50.01 ± 2.76 50.65 ± 4.14 53.05 ± 3.84
PUFA/MUFA 2.67 ± 0.22 1.78 ± 0.17* 2.79 ± 0.31
PUFA/SFA 0.73 ± 0.09 0.66 ± 0.10 0.84 ± 0.14
C20:4n-6/C22:6n-3 1.36 ± 0.19 1.37 ± 0.22 1.43 ± 0.23
C18:0/C18:1 1.17 ± 0.15 0.82 ± 0.25* 1.06 ± 0.12
n-6/n-3 2.06 ± 0.33 2.05 ± 0.23 2.51 ± 0.39
C16:0/C16:1 22.60 ± 8.21 24.38 ± 12.68 29.00 ± 10.45
(a) Mean ± SD, calculated on the basis of peak areas; * significantly dif-
ferent from the control (p<0.05).
(b) Abbreviations: PUFA, polyunsaturated fatty acid; UFA, unsaturated
fatty acid; MUFA, monounsaturated fatty acid; SFA, saturated fatty acid.
TABLE V. Fatty acid composition of the total phospholipids in the
mice submandibular gland samples, expressed in percents, in the
control group and after feeding diets supplemented with 5 g of olive
oil (FOO) and 5 g of corn oil (FCO) to 100 g of standard diet.(a),(b)
Fatty acid Control group FOO group FCO group
C18:2n-6 20.69 ± 0.97 19.05 ± 1.34 22.55 ± 1.47*
C20:2n-6 0.70 ± 0.09 0.48 ± 0.34 0.94 ± 0.09*
C20:3n-6 0.85 ± 0.54 0.86 ± 0.30 0.86 ± 0.41
C20:4n-6 10.12 ± 1.24 9.63 ± 1.97 7.88 ± 1.94
Ón-6 32.36 ± 1.47 30.02 ± 1.70 32.23 ± 2.81
C18:3n-3 0.25 ± 0.01 0.63 ± 0.45 1.74 ± 1.38*
C20:5n-3 1.76 ± 0.10 0.75 ± 0.56* 0.88 ± 0.23*
C22:6n-3 8.37 ± 0.67 7.79 ± 1.63 6.91 ± 2.57
Ón-3 10.38 ± 0.72 9.17 ± 1.79 9.53 ± 3.50
ÓPUFA 42.74 ± 1.61 39.19 ± 3.46 41.76 ± 5.77
C14:0 0.27 ± 0.04 0.25 ± 0.05 0.28 ± 0.17
C16:0 28.48 ± 1.29 28.16 ± 1.40 28.60 ± 3.88
C18:0 11.24 ± 0.53 12.63 ± 0.63* 14.28 ± 1.31*
C20:0 0.33 ± 0.06 0.29 ± 0.11 0.28 ± 0.13
C22:0 0.00 0.00 ± 0.00 0.00 ± 0.00
C24:0 0.43 ± 0.18 0.35 ± 0.15 0.56 ± 0.08
ÓSFA 42.74 ± 1.31 41.68 ± 1.90 44.01 ± 5.09
C16:1n-7 1.44 ± 0.15 1.22 ± 0.17 0.91 ± 0.30*
C18:1n-9 13.63 ± 0.33 17.40 ± 1.78* 13.32 ± 2.13
C20:1n-9 0.67 ± 0.06 0.50 ± 0.45 0.00
ÓMUFA 15.75 ± 0.46 19.13 ± 2.19* 14.23 ± 2.37
ÓUFA 58.49 ± 1.59 58.32 ± 1.90 55.99 ± 5.09
PUFA/MUFA 2.72 ± 0.14 2.08 ± 0.39 3.03 ± 0.76
PUFA/SFA 1.05 ± 0.06 0.94 ± 0.12* 0.97 ± 0.22
C20:4n-6/C22:6n-3 1.22 ± 0.18 1.25 ± 0.17 1.30 ± 0.57
C18:0/C18:1 0.83 ± 0.05 0.73 ± 0.08 1.09 ± 0.20*
n-6/n-3 3.13 ± 0.26 3.37 ± 0.59 3.95 ± 1.97
C16:0/C16:1 19.84 ± 1.39 23.36 ± 3.29* 34.40 ± 12.14*
(a) Mean ± SD, calculated on the basis of peak areas; * significantly
different from the control (p<0.05)
(b) Abbreviations: PUFA, polyunsaturated fatty acid; UFA, unsaturated
fatty acid; MUFA, monounsaturated fatty acid; SFA, saturated fatty acid.
between different FAs is a very important objective, but
this balance is difficult to achieve because FAs are nu-
merous and their physiological functions are multiple
and complex. Imbalanced essential FA ratio has led to an
increase of various metabolic disorders affected by diets
or diseases. In the altering cellular response, FAs do not
act alone. All PUFAs having the 1,4-cis,cis-pentadiene
structure may undergo peroxidation, which can be achi-
eved by cell lipooxygenases or/and cyclooxygenases,
depending on the FA type, affecting the production of
arachidonic acid-derived eicosanoids.
The present work was undertaken to study the tis-
sue-specific PL FA profiles and the effects of the dietary
lipid source on possible modification in the total PL FA
profiles in the examined tissues in mice. We compared
the effects of diets in order to study the nutritional bal-
ance between FAs in the tissue PLs. Distinctive patterns
of FAs were seen in the total PLs in the tissue response
to the diets that contained olive and corn oil. Our data
suggest that dietary induced changes in PL FA profiles
are reflected on the used dietary fat composition and can
influence the fatty acid composition in cell membranes
only in some tissues, mostly in the liver, affecting indi-
vidual fatty acids but not modifying 6- and 9-desa-
turase activities in all tissues. In the liver and spleen (as
lymphatic organs) tissue samples, PUFA content signifi-
cantly decreased with an increase in C18:1n-9 content,
but not in the other studied organs.
Olive oil (n-9 FAs source) and corn oil (n-6 FAs
source) contain different types and amounts of minor
components, such as plant sterols, polyphenols and
squalene, and triacylglycerol (TAG) contents. Contrary
to olive oil, corn oil is refined oil, which changes the na-
ture of PUFAs and the obtained derivates have athero-
genic properties. Blends of vegetable oils were used to
achieve overall diets with 5 g of fat supplements. For ex-
ample, olive oil, which has been shown not to share un-
favorable effects on body weight, may increase triacyl-
glycerols secretion by the liver, depending on the 9
desaturase activity. Dietary squalene, contained in olive
oil, can be used in the regulation of serum cholesterol
concentration, cholesterol synthesis and elimination and
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Figure 1. Significant differences in correlation between the C20:4n-6/C22:6n-3 and n-6/n-3 family fatty acid ratio in examined tissues in
the control (), FOO () and FCO () diet groups, and between C18:0/C18:1n-9 and C16:0/C16:1n-7 ratio in studied tissues in the
control diet group.
in the kinetics of lipoprotein regulation by downre-
gulated hydroxylmethylglutaryl (HMG)-CoA reductase
activity.25 Olive oil polyphenols can also affect the fatty
acid composition in liver tissue.26
The strategy of diet induced changes was largely
based on the balance of monounsaturated FAs with satu-
rated and polyunsaturated FAs. Feeding laboratory ani-
mals diets rich in C18:1n-9 (olive oil) and n-6 fatty acids
(corn oil), significant differences in the tissue PL FA
composition were found only in liver tissue (p = 0.0032).
However, the differences existing in individual fatty acid
proportions were found in all examined tissues, as can
be seen in Tables II, III, IV and V. Compared to the con-
trol, MUFAs were significantly elevated and PUFAs were
suppressed in the liver and spleen in the diet rich in
C18:1n-9. C18:1n-9 significantly differs in the FOO and
from that in the control group, as well as PUFA/MUFA,
PUFA/SFA, n-6/n-3 and C20:4n-6/C22:6n-3 ratios. C22:
6n-3 and C20:4n-6 were decreased when C18:1n-9 was
increased in the liver. PUFAs balance is better represent-
ed by the ratios between n-3 and n-6 FAs. We found that
C18:1n-9 negatively correlated with C20:4n-6 (r = –0.65)
in all tissues in the control group. According to Ding and
Mersmann,27 the main effect of C18:1n-9 is regulating the
gene expression rather than changing the membrane flu-
idity as a result of changing the membrane FA composi-
tion. Our data suggest that these changes were affected
by the used diet depending of tissue types.
The ratio n-6/n-3 differs significantly between tis-
sues, with the submandibular gland having the highest
ratio value and liver the lowest, as well as the ratio value
of C20:4n-6/C22:6n-3. Furthermore, mammals have 5
and 6-desaturase, which provide PUFAs for incorpora-
tion into the membrane and for eicosanoid synthesis. Mo-
reno et al.28 found that olive oil diet reduces C20:4n-6
release and subsequent production of arachidonic acid
metabolites by the prostaglandin G/H synthase-2 path-
way and induces less oxidative stress in macrophages in
rats fed the olive oil than in those fed the fish oil diet.
Liver tissues responded with significant differences.
C18:2n-6, C18:0 and C20:4n-6 were significantly ele-
vated, C18:1n-9 and C16:0 were significantly suppressed
in the FCO group compared to the control. The highest
C20:4n-6/C22:6n-3 ratio in all tissues belonged to the
animals fed corn oil. The increase in the C20:4n-6 propor-
tion, like in C20:4n-6/C22:6n-3 ratio, indicated the possi-
bility of eicosanoid production prior to other used diet
types. n-6 fatty acids were significantly higher and n-3
were lower in the liver tissue than in the control. Modern
Western diet changes the n-6 and n-3 ratio of PUFAs in
the diet, thus the relative deficiency of n-3 PUFAs
(C15–C20:1) was found.
The highest proportion of C16:0 was found in the
lung. Pulmonary surfactant contains C16:0 in the phos-
phatidylcholine fraction, which is essential for normal
lung function because it reduces surface tension at the
air-liquid interface of alveolar space.29 PUFAs were ele-
vated in the lung if the FCO and FCO diets were com-
pared to the control. C18:1n-9 was significantly increas-
ed in the FOO and C18:2n-6 in the FCO diet group in
the lung. Diets containing C20:5n-3 or C20:5n-3 + C18:
2n-6 alter the PUFA composition of pulmonary surfac-
tants in the pigs.30 Minimal surface tension was elevated
by suppressed C18:2n-6 content.30,31 Analogously, our
data suggest a higher minimal surface tension in the lung
in the FCO group.
The C18:0/C18:1n-9 and C16:0/C16:1n-7 ratios dif-
fer significantly between tissues, with the liver having the
highest and lung the lowest ratio value. The C16:0/C16:1n-7
ratio was higher than C18:0/C18:1n-9 ratio in all tissues,
which reflected a higher proportion of C16:0. These sig-
nificantly elevated ratios in the lung and submandibular
gland in mice fed corn oil suggested a lower activity of
SCD and palmitoyl-CoA desaturase (PCD). The SCD
plays an important role in the synthesis of monounsatu-
rated FAs and the construction of membrane PLs and li-
pid metabolism. Enzymatic activity of SCD was increas-
ed by the C16:1n-7 and C18:1n-9 content in TAG32 like
in total PLs in liver tissue presented in our data. In rats,
the activity of SCD enzymes is regulated by diets, hor-
mone balance, developmental state, etc.33 Lipoproteins
regulation can be possible by modulating the SCD activ-
ity.34,35 Oleic acid could not reduce the transcription of
the SCD genes either in vivo or in vitro.36,37,38
The tissue FAs profile plays an important role before
and after induced oxidative stress. Diet intervention mo-
dified this profile, and in this way reduced dysfunctions
in the eicosanoid metabolism and disorders such as car-
diovascular and gastrointestinal diseases as well as the
incidence of cancer. These disorders have been linked to
an imbalanced PUFA intake, related to diets with high
n-6 and/or n-3 balance similar to high n-3 diet. The bio-
logical plausibility of any diet and health relationship is
crucial when deciding whether or not it is worthy of as-
sessment. This work has presented the tissue PL FA pro-
file before induced stress with and without diet interven-
tion, which can be the »starting position« for investigat-
ing various diseases and their prevention. The data pre-
sented here support the hypothesis that changes induced
by diet corn oil increase linoleic acid, whereas olive oil
increases the oleic acid content in the total phospholipid
fatty acid composition in the majority of the examined
tissues. Liver tissue was most affected by the used diet.
Acknowledgements. – This work was supported by the
Croatian Ministry of Science, Project No. 0062002. Students
of the School of Medicine, University of Rijeka, Marko Mrko-
vi}, Dalibor Lisko, Irena Dobrila and Maja Ceci}-Vido{ par-
ticipated in this work.
DIET INDUCED CHANGES INTO TISSUES 403
Croat. Chem. Acta 78 (3) 397¿404 (2005)
REFERENCES
1. W. T. Cave, Jr., FASEB J. 5 (1991) 2160–2166.
2. E. Duplus, M. Glorian, and C. Forest, J. Biol. Chem. 275
(2000) 30749–30752.
3. C. Wolfrum and F. Spener, Eur. J. Lipid Sci. Technol. 102
(2000) 746–762.
4. T. Lemberger, W. Desvergne, and W. Wahli, Annu. Rev. Cell
Dev. Biol. 12 (1996) 335–363.
5. P. Escher and W. Wahli, Mutat. Res. 448 (2000) 121–138.
6. S. A. Kliewer, B. M. Forman, B. Blumberg, E. S. Ong, U.
Borgmeyer, D. J. Mangelsdorf, K. Umesono, and R. M. Ev-
ans, Proc. Natl. Acad. Sci. USA 91 (1994) 7355–7359.
7. R. Jeffcoat and A. T. James, FEBS Lett. 85 (1978) 114–118.
8. J. M. Ntambi, J. Lipid Res. 40 (1999) 1549–1558.
9. P. M. Kris-Etherton, Circulation 100 (1999) 1253–1258.
10. J. M. Ntambi, Prog. Lipid Res. 34 (1995) 139–150.
11. Y. C. Kim and J. M. Ntambi, Biochem. Biophys. Res. Com-
mun. 266 (1999) 1–4.
12. M. T. Clandinin, S. Cheema, C. J. Field, M. L. Garg, J. Ven-
katraman, and T. R. Clandinin, FASEB J. 5 (1991) 2761–
2769.
13. A. A. Spector and M. A. Yorek, J. Lipid Res. 26 (1985)
1015–1035.
14. J. E. Kinsella, B. Lokesh, and R. A. Stone, Am. J. Clin. Nutr.
52 (1990) 1–28.
15. J. E. Kinsella, JPEN J. Parenter. Enteral Nutr. 14 (1990)
200S–217S.
16. B. Jones, M. A. Maher, W. J. Banz, M. B. Zemel, J. Whe-
lan, P. Smith, and N. Moustaid, Am. J. Physiol. 271 (1996)
E44-E49.
17. D. A. Pan, A. J. Hulbert, and L. H. Storlien, J. Nutr. 124
(1994) 1555–1565.
18. J. Li, S-F. Ding, N. A. Habbib, B. F. Fermor, C. B. Wood,
and R. S. Gilmour, Int. J. Cancer 57 (1994) 348–352.
19. N. A. Habib, C. B. Wood, K. Apostolov, W. Barker, M. J.
Hershman, M. Aslam, D. Heinemann, B. Fermor, R. C. N.
Williamson, are W. E. Jenkins, Br. J. Cancer 56 (1987) 455–
458.
20. D. E. Khoo, B. Fermor, J. Miller, C. B. Wood, K. Aposto-
lov, W. Barker, R. C. N. Williamson, and N. A. Habib, Br. J.
Cancer 63 (1991) 97–101.
21. B. Garbay, F. Boiron-Sargueil, M. Shy, T. Chbihi, H. Jiang,
J. Kamholz, and C. Cassagne, J. Neurochem. 71 (1998) 1719–
1726.
22. EEC Directive 2568 (1991) No. L248, 1–83.
23. J. Giacometti, A. Milo{evi}, and ^. Milin, J. Chromatogr.,
Sect. A 976 (2002) 47–54.
24. J. Folch, M. Lees, and G. H. S. Stanley, J. Biol. Chem. 226
(1957) 497–509.
25. T. Miettinen and H. Vanhanen, Am. J. Clin. Nutr. 59 (1994)
356–63.
26. F. Benkhalti, J. Prost, E. Paz, F. Perez-Jimenez, C. El Mo-
dafar, and E. El Boustani, Nutr. Res. 22 (2002) 1067–1075.
27. S. T. Ding and H. J. Mersmann, J. Nutr. Biochem. 12 (2)
(2001) 101–108.
28. J. J. Moreno, T. Carbonell, T. Sánchez, S. Miret, and M. T.
Mitjavila, J. Nutr. 131 (2001) 2145–2149.
29. W. Bernhard, S. Hoffmann, H. Dombrowsky, G. A. Rau, A.
Kamlage, M. Kappler, J. J. Haitsma, J. Freihorst, H. von der
Hardt, and C. F. Poets, Am. J. Respir. Cell Mol. Biol. 25
(2001) 725–731.
30. M. J. Murray, G. Kanazi, K. Moukabary, H. D. Tazelaar,
and S. J. DeMichele, CHEST 117 (2000) 1720–1727.
31. J. D. Palombo, E. E. Lydon, P. L. Chen, B. R. Bistrian, and
R. A. Forse, Lipids 29 (1994) 643–649.
32. R. Kasturi and V. C. Joshi, J. Biol. Chem. 257 (1982) 12224–
12230.
33. D. E. Tabor, J. B. Kim, B. M. Spiegelman, and P. A. Ed-
wards, J. Biol. Chem. 274 (1999) 20603–20610.
34. T. Nakatani, H. J. Kim, Y. Kaburagi, K. Yasuda, and O.
Ezaki, J. Lipid Res. 44 (2003) 369–379.
35. W. Reuter, B. Vorberg, K. Krumpolt, and I. Sauer, Z.
Ernährungswiss. 34 (1995) 151–159.
36. J. M. Ntambi, J. Biochem. 267 (1992) 10925–10930.
37. P. W. Tebbey and T. M. Buttke, Biochim. Biophys. Acta
1171 (1992) 27–34.
38. K. M. Waters and J. M. Ntambi, J. Biol. Chem. 269 (1994)
27773–27777.
SA@ETAK
Utjecaj prehrane oboga}ene n-6 i n-9 masnim kiselinama na ugradnju masnih kiselina
u tkivne fosfolipide mi{a
Jasminka Giacometti, ^edomila Milin, Marin Tota, Mira ]uk i Biserka Rado{evi}-Sta{i}
Cilj je ovoga rada bio istra`iti sastav masnih kiselina u fosfolipidima jetre, plu}a, slezene i submandibular-
ne `lijezde u mi{a te odrediti utjecaj prehranom une{enih masnih kiselina na sastav masnih kiselina ukupnih
fosfolipida. U svim istra`ivanim tkivima najzastupljenije zasi}ene kiseline su palmitinska (C16:0) i stearinska
(C18:0) kiselina, a oleinska kiselina (C18:1n-9) je najzastupljenija jednostrukonezasi}ena kiselina. Dokoza-
heksaenska kiselina (C22:6n-3) je najzastupljenija vi{estrukonezasi}ena kiselina u jetri i plu}ima, arahidonska
kiselina (C20:4n-6) u slezeni, a linoleinska kiselina (C18:2n-6) u tkivu submandibularne `lijezde. Dobiveni re-
zultati podupiru hipotezu da je prehrana oboga}ena kukuruznim uljem utjecala na pove}anje linoleinske kiseline
(C18:2n-6), a prehrana oboga}ena maslinovim uljem na pove}anje oleinske kiseline (C18:1n-9) u fosfolipidima
istra`ivanih tkiva. Primjenjena prehrana najvi{e je utjecala na lipide tkiva jetre.
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